Compared with the preceding meta-analysis, our meta-analysis is the first one to demonstrate that MMPs family may be biomarkers for worse prognosis on breast cancer patients, including not only the aforementioned MMP-2 and MMP-9, but also MMP-1, MMP-11, MMP-13 and MMP-14. This evidence concerns the gene MMP9 and breast cancer.